---
schema_version: "secwatch.filing_event.v1"
accession: "0001722482-25-000077"
form_type: "8-K"
ticker: "AVTR"
cik: "0001722482"
company_name: "Avantor, Inc."
filed_at: "2025-04-25T23:59:59+00:00"
generated_at: "2026-05-23T05:54:51.306357+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Avantor Q1 net sales down 6% to $1.58B; organic decline 2%; adjusted EPS $0.23

## Summary
- Net sales $1,581.4M (-6% reported, -2% organic); net income $64.5M ($0.09 GAAP EPS); adjusted EPS $0.23.
- Lab Solutions sales $1,065M (-8% reported, -3% organic); Bioscience Production $516.4M (-1%, flat organic).
- Adjusted EBITDA $269.5M (17.0% margin); operating cash flow $109.3M; free cash flow $82.1M.
- Cost transformation target raised to $400M gross run-rate savings by exit 2027; full-year outlook updated for policy headwinds.
- Management cites reduced demand in Education & Government end market; net leverage 3.2x.

## SEC filing metadata
- accession: 0001722482-25-000077
- form_type: 8-K
- ticker: AVTR
- cik: 0001722482
- company_name: Avantor, Inc.
- filed_at: 2025-04-25T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1722482/000172248225000077/0001722482-25-000077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1722482/000172248225000077/avtr-20250425.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001722482-25-000077
- JSON: https://secwatch.observer/filing/0001722482-25-000077.json
- Plain text: https://secwatch.observer/filing/0001722482-25-000077.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.